The FDA’s fast-track drug review program has evolved into a tool for the White House to steer which medications reach patients most quickly. This initiative influences the timeline for drug approvals, impacting how swiftly critical treatments become available.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More